Fujifilm India has reported a 12 per cent increase in sales to over Rs 1,000 crore last fiscal, mainly driven by medical systems, photo imaging and graphic arts segment.
The company had posted overall sales revenue of Rs 899 crore in 2014-15 fiscal, said Fujifilm India in a statement.
During the fiscal, the company had launched various new products in the Indian market including its Instax range of instant cameras.
In medical systems, the company had introduced Amulet Innovality, a highly advanced breast cancer diagnostic machine enabling early detection of breast cancer with its 50 Micron 3D image quality, and advanced tomosynthesis technology.
Fujifilm India Managing Director Yasunobu Nishiyama said: "We are witnessing a promising future for ourselves in the Indian market and FY 2015-16 success can be largely attributed to our innovative products and long-term commitment towards our customers and partners."
The company had installed Amulet Innovality in many top private and government hospitals in India and is promoting the importance of early detection.
On the outlook, Nishiyama said: "I am confident that we will continue to grow and dominate an even larger share in the respective divisions. We are very excited on our India journey and look forward to achieve 20 per cent growth in FY 2016-17."
Fujifilm India is a wholly-owned subsidiary of Tokyo-based Fujifilm Holdings Corporation.
